Global Retirement Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $4.14M | Sell |
145,171
-35,011
| -19% | -$931K | 0.06% | 281 |
|
|
2026
Q2 | $4.34M | Sell |
180,182
-36,320
| -17% | -$950K | 0.07% | 268 |
|
|
2025
Q4 | $5.39M | Buy |
216,502
+81,713
| +61% | +$2.06M | 0.1% | 196 |
|
|
2025
Q3 | $3.43M | Sell |
134,789
-1,068
| -0.8% | -$26.4K | 0.08% | 238 |
|
|
2025
Q2 | $3.29M | Buy |
135,857
+31,272
| +30% | +$729K | 0.08% | 225 |
|
|
2024
Q4 | $2.77M | Sell |
104,585
-24,744
| -19% | -$671K | 0.08% | 240 |
|
|
2024
Q3 | $3.74M | Sell |
129,329
-116
| -0.1% | -$3.38K | 0.11% | 175 |
|
|
2024
Q2 | $3.62M | Buy |
129,445
+24,709
| +24% | +$680K | 0.11% | 180 |
|
|
2024
Q1 | $2.91M | Buy |
104,736
+6,774
| +7% | +$188K | 0.11% | 188 |
|
|
2023
Q4 | $2.77M | Sell |
97,962
-5,740
| -6% | -$174K | 0.12% | 176 |
|
|
2023
Q3 | $3.45M | Sell |
103,702
-6,961
| -6% | -$246K | 0.17% | 119 |
|
|
2023
Q2 | $4.06M | Buy |
110,663
+11,735
| +12% | +$457K | 0.2% | 112 |
|
|
2023
Q1 | $3.8M | Buy |
98,928
+8,437
| +9% | +$364K | 0.2% | 111 |
|
|
2022
Q4 | $4.64M | Buy |
90,491
+7,927
| +10% | +$380K | 0.32% | 66 |
|
|
2022
Q3 | $3.84M | Buy |
82,564
+4,719
| +6% | +$229K | 0.29% | 76 |
|
|
2022
Q2 | $4.08M | Buy |
77,845
+311
| +0.4% | +$15.8K | 0.33% | 72 |
|
|
2022
Q1 | $4.14M | Buy |
77,534
+21,232
| +38% | +$1.1M | 0.33% | 69 |
|
|
2021
Q4 | $3.32M | Sell |
56,302
-2,107
| -4% | -$104K | 2.57% | 9 |
|
|
2021
Q3 | $2.51M | Buy |
58,409
+917
| +2% | +$40.6K | 0.25% | 86 |
|
|
2021
Q2 | $2.25M | Buy |
57,492
+1,098
| +2% | +$42.7K | 0.23% | 97 |
|
|
2021
Q1 | $2.04M | Buy |
56,394
+557
| +1% | +$19.8K | 0.24% | 87 |
|
|
2020
Q4 | $2.06M | Sell |
55,837
-4,931
| -8% | -$181K | 0.26% | 75 |
|
|
2020
Q3 | $2.23M | Buy |
60,768
+1,748
| +3% | +$64.6K | 0.33% | 66 |
|
|
2020
Q2 | $1.93M | Sell |
59,020
-628
| -1% | -$22.5K | 0.31% | 62 |
|
|
2020
Q1 | $1.95M | Sell |
59,648
-6,171
| -9% | -$222K | 0.37% | 57 |
|
|
2019
Q4 | $2.58M | Buy |
65,819
+95
| +0.1% | +$3.57K | 0.4% | 53 |
|
|
2019
Q3 | $2.36M | Buy |
65,724
+21,459
| +48% | +$822K | 0.39% | 56 |
|
|
2019
Q2 | $1.92M | Buy |
44,265
+9,750
| +28% | +$408K | 0.37% | 54 |
|
|
2019
Q1 | $1.47M | Sell |
34,515
-575
| -2% | -$24.3K | 0.35% | 56 |
|
|
2018
Q4 | $1.53M | Sell |
35,090
-148
| -0.4% | -$6.48K | 0.39% | 57 |
|
|
2018
Q3 | $1.55M | Sell |
35,238
-36
| -0.1% | -$1.46K | 0.35% | 60 |
|
|
2018
Q2 | $1.28M | Buy |
35,274
+411
| +1% | +$14.8K | 0.32% | 59 |
|
|
2018
Q1 | $1.24M | Sell |
34,863
-5,297
| -13% | -$192K | 0.34% | 59 |
|
|
2017
Q4 | $1.46M | Buy |
40,160
+17,272
| +75% | +$621K | 0.4% | 39 |
|
|
2017
Q3 | $817K | Buy |
22,888
+1,508
| +7% | +$51.1K | 0.34% | 54 |
|
|
2017
Q2 | $718K | Buy |
21,380
+3,290
| +18% | +$109K | 0.34% | 55 |
|
|
2017
Q1 | $619K | Buy |
18,090
+1,001
| +6% | +$33.3K | 0.35% | 56 |
|
|
2016
Q4 | $555K | Hold |
17,089
| – | – | 0.37% | 52 |
|
Other funds holding PFE
Global Retirement Partners's PFE Position: Q3 2026 in Review
Global Retirement Partners reduced its Pfizer (PFE) stake by 19% in Q3 2026, selling an estimated $931K and leaving 145,171 shares worth $4.14M. The position accounts for 0.06% of the portfolio, ranked #281.
Global Retirement Partners first reported a position in PFE in Q4 2016 and has held it in 38 quarters since. The position peaked at $5.39M in Q4 2025. 2,918 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Global Retirement Partners held 145,171 shares of Pfizer worth $4.14M as of Q3 2026.
- Global Retirement Partners sold 35,011 Pfizer shares in Q3 2026, an estimated $931K.
- Pfizer made up 0.06% of Global Retirement Partners's portfolio in Q3 2026, its #281 holding.
- Global Retirement Partners first reported a position in Pfizer in Q4 2016 and has held it in 38 quarters since.
- Global Retirement Partners's Pfizer position peaked at $5.39M in Q4 2025.
- 2,918 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Global Retirement Partners's 13F filing for Q3 2026, filed 10 Nov 2026.